The effect of homoharringtonine in patients with chronic myeloid leukemia who have failed or responded suboptimally to imatinib therapy

Leuk Lymphoma. 2009 Nov;50(11):1889-91. doi: 10.3109/10428190903216838.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Agents, Phytogenic / therapeutic use
  • Benzamides
  • Drug Resistance, Neoplasm
  • Drug Therapy, Combination
  • Harringtonines / therapeutic use*
  • Homoharringtonine
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Piperazines / therapeutic use*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / therapeutic use*
  • Remission Induction
  • Young Adult

Substances

  • Antineoplastic Agents, Phytogenic
  • Benzamides
  • Harringtonines
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Homoharringtonine
  • Imatinib Mesylate